436 related articles for article (PubMed ID: 34098873)
1. Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study.
Suzuki K; Takeshima T; Igarashi H; Imai N; Danno D; Yamamoto T; Nagata E; Haruyama Y; Mitsufuji T; Suzuki S; Ito Y; Shibata M; Kowa H; Kikui S; Shiina T; Okamura M; Tatsumoto M; Hirata K
J Headache Pain; 2021 Jun; 22(1):53. PubMed ID: 34098873
[TBL] [Abstract][Full Text] [Related]
2. Impact of Headache Frequency and Sleep on Migraine Patients During the COVID-19 Pandemic.
Ma M; Bao J; Fang J; Li C; Li Y; Ge W; Zhang Y; Guo J; He L
Curr Neurovasc Res; 2021; 18(1):4-11. PubMed ID: 33719972
[TBL] [Abstract][Full Text] [Related]
3. Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study.
Al-Hashel JY; Ismail II
J Headache Pain; 2020 Sep; 21(1):115. PubMed ID: 32972360
[TBL] [Abstract][Full Text] [Related]
4. The effect of the COVID-19 pandemic on headache-related disability among young adults with migraine.
Thaxter LY; Smitherman TA
Headache; 2022 Nov; 62(10):1293-1301. PubMed ID: 36419255
[TBL] [Abstract][Full Text] [Related]
5. Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms.
Stewart WF; Lipton RB; Kolodner K
Headache; 2003 Mar; 43(3):258-65. PubMed ID: 12603645
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates of insomnia in patients with persistent post-traumatic headache compared with migraine.
Kim SK; Chong CD; Dumkrieger G; Ross K; Berisha V; Schwedt TJ
J Headache Pain; 2020 Apr; 21(1):33. PubMed ID: 32295535
[TBL] [Abstract][Full Text] [Related]
7. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
[TBL] [Abstract][Full Text] [Related]
8. The impact of COVID-19 pandemic on headache symptoms and drug withdrawal among patients with medication overuse headache: a cross-sectional study.
Li C; Li Y; Ma M; Zhang Y; Bao J; Ge W; Liu Y; Peng C; He L
J Headache Pain; 2021 May; 22(1):41. PubMed ID: 34020588
[TBL] [Abstract][Full Text] [Related]
9. The impact of Coronavirus disease 2019 (COVID-19) pandemic on migraine disorder.
Haghdoost F; Carcel C; Chandrasekhar D; Rodgers A; Delcourt C
J Neurol; 2021 Dec; 268(12):4429-4435. PubMed ID: 33950336
[TBL] [Abstract][Full Text] [Related]
10. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score.
Stewart WF; Lipton RB; Whyte J; Dowson A; Kolodner K; Liberman JN; Sawyer J
Neurology; 1999 Sep; 53(5):988-94. PubMed ID: 10496257
[TBL] [Abstract][Full Text] [Related]
11. An Internet-based study on the impact of COVID-19 pandemic-related lockdown on migraine in India.
Chowdhury D; Krishnan A; Duggal A; Datta D; Mundra A; Deorari V; Tomar A; Koul A
Acta Neurol Scand; 2021 Dec; 144(6):706-716. PubMed ID: 34459497
[TBL] [Abstract][Full Text] [Related]
12. Investigating the relationships between the burden of multiple sensory hypersensitivity symptoms and headache-related disability in patents with migraine.
Suzuki K; Suzuki S; Shiina T; Okamura M; Haruyama Y; Tatsumoto M; Hirata K
J Headache Pain; 2021 Jul; 22(1):77. PubMed ID: 34281498
[TBL] [Abstract][Full Text] [Related]
13. Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users.
Kato Y; Poh W; Horvath Z; Cadiou F; Shimazu T; Maruki Y
BMC Neurol; 2021 Sep; 21(1):345. PubMed ID: 34503456
[TBL] [Abstract][Full Text] [Related]
14. Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR).
Pearl TA; Dumkrieger G; Chong CD; Dodick DW; Schwedt TJ
Headache; 2020 Oct; 60(9):1910-1919. PubMed ID: 32749685
[TBL] [Abstract][Full Text] [Related]
15. The role of personality, disability and physical activity in the development of medication-overuse headache: a prospective observational study.
Mose LS; Pedersen SS; Debrabant B; Jensen RH; Gram B
J Headache Pain; 2018 May; 19(1):39. PubMed ID: 29802536
[TBL] [Abstract][Full Text] [Related]
16. Depressive symptoms and insecure attachment as predictors of disability in a clinical population of patients with episodic and chronic migraine.
Rossi P; Di Lorenzo G; Malpezzi MG; Di Lorenzo C; Cesarino F; Faroni J; Siracusano A; Troisi A
Headache; 2005 May; 45(5):561-70. PubMed ID: 15953275
[TBL] [Abstract][Full Text] [Related]
17. Migraine-related disability and co-morbid depression among migraineurs in Ethiopia: a cross-sectional study.
Ayele BA; Yifru YM
BMC Neurol; 2018 Jul; 18(1):95. PubMed ID: 29966529
[TBL] [Abstract][Full Text] [Related]
18. Psychological factors associated with headache frequency, intensity, and headache-related disability in migraine patients.
Klonowski T; Kropp P; Straube A; Ruscheweyh R
Neurol Sci; 2022 Feb; 43(2):1255-1266. PubMed ID: 34304327
[TBL] [Abstract][Full Text] [Related]
19. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.
Bigal ME; Rapoport AM; Lipton RB; Tepper SJ; Sheftell FD
Headache; 2003 Apr; 43(4):336-42. PubMed ID: 12656704
[TBL] [Abstract][Full Text] [Related]
20. Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire.
Iigaya M; Sakai F; Kolodner KB; Lipton RB; Stewart WF
Headache; 2003 Apr; 43(4):343-52. PubMed ID: 12656705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
